1 6 2
O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E | S E P T E M B E R 2 0 1 4
W
hen propofol was in short supply, anesthesia providers
often complained that the drug's large, single-use-only vials
led to excessive waste after short cases in which only a
small amount of the IV sedative-hypnotic was needed. With the intro-
duction of propofol packaged in smaller vials, however, a German
pharmaceutical manufacturer is offering an effective solution.
Fresenius Kabi is the first drug maker to market Diprivan (propo-
fol) injectable emulsion, USP, in 10 mL vials. The company received
FDA approval for the portioning, which joins its 20 mL, 50 mL and
100 mL sizes, in June. "Many [providers and managers] expressed a
real need for a 10mL presentation," says company spokesman Matt
PROPERLY PACKAGED PROPOFOL
Drug Maker Introduces Propofol in 10 mL Vials
PRODUCT
News
PRACTICAL PORTION Smaller vials of propofol
could reduce waste and support safety.
Great ideas for your OR
